Unlocking the power of real-world data – New podcast episode

Research / 31 March 2023

Real-world data is a rich source of evidence for pharmacovigilance, but there are challenges yet to be faced before unlocking its true potential as a resource.

Real-world data, or observational data collected during routine clinical care, could be a valuable source of evidence in pharmacovigilance. However, there are still hurdles to overcome before it can deliver on that value.

In the latest episode of the Drug Safety Matters podcast, Federica Santoro and Patrick Ryan from Johnson & Johnson discuss the challenges of using real-world data for patient safety and how this resource may be harnessed for pharmacovigilance through some ‘proof of concept’ projects such as OHDSI and EHDEN.

Like what you hear? Then subscribe to the podcast by visiting the Drug Safety Matters website.

You may also like

UMC science gets personal

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

Research / 16 March 2023

Optimising COVID-19 vaccine safety surveillance in the Netherlands

By utilising automated web reporting and a triage sorting system, the pharmacovigilance centre Lareb enabled near real-time processing of over 200 000 COVID-19 vaccine AEFI reports

Research / 27 March 2023

Expanding sources of evidence for better signal detection – New podcast out now

In this digital age, can pharmacovigilance experts leverage on new types of data to find evidence for signals? Listen to the latest Drug Safety Matters podcast to find out.

Research / 23 February 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more